Answers are grounded in this paper and cite their sources.
Multivariable risk model enhances detection of clinically significant prostate cancer, suggesting better clinical strategies.
Integrating PSAD with PI-RADS improved csPCa risk stratification compared with PI-RADS alone, with predominant benefit as a biopsy-sparing, rule-out adjunct. External validation is required for clinical implementation.
No takes yet. Share an insight, caveat, or question.
YUNUS KAYALI (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: